Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid-binding protein excretion in patients with diabetic nephropathy

Metabolism: Clinical and Experimental

Volumn 58, Issue 8, 2009, Pages 1185-1190

  Nakamura, Tsukasa ^a   Fujiwara, Nobuharu ^a   Sugaya, Takeshi ^b   Ueda, Yoshihiko ^c   Koide, Hikaru ^d  

^a Shinmatsudo Central General Hospital   (Japan)

^b RIKEN KOBE INSTITUTE   (Japan)

^c DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KOTO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CREATININE; FATTY ACID BINDING PROTEIN; HEMOGLOBIN A1C;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RED WINE; RENAL PROTECTION; URINARY EXCRETION; WHITE WINE; WINE;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; DEOXYGUANOSINE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROTEINURIA; TIME FACTORS; WINE;

EID: 67651096089     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.03.019     Document Type: Article

References (31)

1. Perez D.D., Strobel P., Foncea R., et al. Wine, diet, antioxidant defenses, and oxidative damage. Ann N Y Acad Sci 957 (2002) 136-145
2. Rodrigo R., and Rivera G. Renal damage mediated by oxidative stress: a hypothesis of protective effects of red wine. Free Radical Biol Med 33 (2002) 409-422
3. Kim H.Y., Kim O.H., and Sung M.K. Effects of phenol-depleted and phenol-rich diets on blood markers of oxidative stress, and urinary excretion of quercetin and kaempferol in healthy volunteers. J Am Coll Nutr 22 (2003) 217-223
4. Pechanova O., Rezzani R., Babal P., Bernatova I., and Andriantsitohaina R. Beneficial effects of provinols: cardiovascular system and kidney. Physiol Res 55 Suppl 1 (2006) S17-S30
5. Sharma S., Anjaneyulu M., Kulkarni S.K., and Chopra K. Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats. Pharmacology 76 (2006) 69-75
6. Marfella R., Cacciapuoti F., Siniscalchi M., et al. Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with type 2 diabetes mellitus. Diabet Med 23 (2006) 974-981
7. Pignatelli P., Ghiselli A., Buchetti B., et al. Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine. Atherosclerosis 188 (2006) 77-83
8. Kamijo-Ikemori A., Sugaya T., Obama A., et al. Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction. Am J Pathol 169 (2006) 1107-1117
9. Xu G.W., Yao O.H., Weng O.F., et al. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy. J Pharm Biomed Anal 36 (2004) 101-104
10. Kanauchi M., Nishioka H., and Hashimoto T. Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron 91 (2002) 327-329
11. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 22 Suppl 1 (1999) S5-S19
12. Marfella R., Cacciapuoti F., Siniscalchi M., et al. Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with type 2 diabetic mellitus. Diabetic Med 23 (2006) 974-981
13. Kamijo A., Kimura K., Sugaya T., et al. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med 143 (2004) 23-30
14. Saito S., Yamauchi H., Hasui Y., Kurashige J., Ochi H., and Yoshida K. Quantitative determination of urinary 8-hydroxydeoxyguanosine (8-OH-dg) by using ELISA. Res Commun Mol Pathol Pharmacol 107 (2000) 39-44
15. Nakamura T., Sugaya T., Kawagoe Y., Ueda Y., Osada S., and Koide H. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy. Diabetes Care 28 (2005) 2728-2732
16. Gilbert R.E., and Cooper M.E. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?. Kidney Int 56 (1999) 1627-1637
17. Dounousi E., Papavasiliou E., Makedou A., et al. Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis 48 (2006) 752-760
18. Shalamanova L., McArdle F., Amara A.B., Jackson M.J., and Rustom R. Albumin overload induces adaptive responses in human proximal tubular cells through oxidative stress but not via angiotensin II type 1 receptor. Am J Physiol Renal Physiol 292 (2007) F1846-F1857
19. Rodrigo R., and Bosco C. Oxidative stress and protective effects of polyphenols: comparative studies in human and rodent kidney. A review. Comp Biochem Physiol Toxicol 142 (2006) 317-327
20. Martinez J., and Moreno J. Effect of resveratrol, a natural polyphenolic compound on reactive oxygen species and prostaglandin production. Biochem Pharmacol 59 (2000) 865-870
21. Feng Y.H., Zou J.P., and Li X.Y. Effects of resveratrol and ethanol on production of pro-inflammatory factors from endotoxin-activated murine macrophages. Acta Pharmacol Sin 23 (2002) 1002-1006
22. Nakamura T., Sugaya T., and Koide H. Cigarette smoking affects urinary liver-type fatty acid-binding protein concentration in patients with early diabetic nephropathy. Diabetes Care 29 (2006) 1717
23. Nakamura T., Ushiyama C., Shimada N., et al. Effect of the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage of diabetic nephropathy. Diabetes Care 23 (2000) 1168-1171
24. Nakamura T., Sugaya T., Kawagoe Y., Ueda Y., and Koide H. Effect of pioglitazone on urinary liver-type fatty acid binding protein concentrations in diabetes patients with microalbuminuria. Diabetes Metab Res Rev 22 (2006) 385-389
25. Cui J., Tosaki A., Cordis G.A., et al. Cardioprotective abilities of white wine. Ann N Y Acad Sci 957 (2002) 308-316
26. Dudley J.I., Lekli I., Mukherjee M., Bertelli A.A., and Das D.K. Does white wine qualify for French paradox? Comparison of the cardioprotective effects of red and white wines and their constituents, resveratol, tyrosol, and hydroxytyrosol. J Agric Food Chem 56 (2008) 9362-9373
27. Sarr M., Chataigneau M., Martins S., et al. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase. Cardiovasc Res 71 (2006) 794-802
28. Pechanova O., Bernatova I., Babal P., et al. Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. J Hypertens 22 (2004) 1551-1559
29. de Moura R.S., Miranda D.Z., Pinto A.C., et al. Mechanism of the endothelium-dependent vasodilation and the antihypertensive effect of Brazilian red wine. J Cardiovasc Phamacol 44 (2004) 302-309
30. Mozaffarieh M., Grieshaber M.C., Orgul S., and Flammer J. The potential value of natural antioxidative treatment in glaucoma. Surv Opthalmol 53 (2008) 479-505
31. Lopez-Sepulveda R., Jimenez R., Romero M., et al. Wine polyphenols improve endothelial function in large vessels of female spontaneously hypertensive rates. Hypertension 51 (2008) 1088-1095